Physician profile
Angela E Watson
NPI 1003823022
$1,458.58
in general payments reported to CMS, 2019-2025
17 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $239 · 2023: $252 · 2024: $525 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.80 |
| Education | $146.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $518.08 | 2022-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $211.94 | 2021-2023 | |
| Janssen Biotech, INC. | $122.80 | 2023-2025 | Erleada |
| Janssen Pharmaceuticals, INC | $120.00 | 2021 | |
| Laborie Medical Technologies Corp. | $93.10 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $83.98 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $63.07 | 2023-2025 | Lynparza |
| Sumitomo Pharma America, INC. | $57.56 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $41.91 | 2023-2025 | Eligard, Jatenzo |
| United Therapeutics Corporation | $29.24 | 2024 | Tyvaso |
| Abbvie INC. | $24.46 | 2022 | |
| Stryker Corporation | $20.85 | 2025 | Sdc3 |
| Ferring Pharmaceuticals INC. | $20.70 | 2024 | Adstiladrin |
| Pfizer INC. | $20.59 | 2024 | |
| Novartis Pharmaceuticals Corporation | $18.98 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7.50 | 2025 | Axonics |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.